Antidepressants and the Risk of Type 2 Diabetes Mellitus Among Publicly-Insured US Youth

被引:0
|
作者
Burcu, Mehmet [1 ]
Zito, Julie M. [1 ,2 ]
Dosreis, Susan [1 ]
Shaya, Fadia T. [1 ]
Safer, Daniel J. [3 ,4 ]
机构
[1] Univ Maryland, Dept Pharmaceut Hlth Serv Res, Baltimore, MD 21201 USA
[2] Univ Maryland, Dept Psychiat, Baltimore, MD 21201 USA
[3] Johns Hopkins Med Inst, Dept Psychiat, Baltimore, MD 21205 USA
[4] Johns Hopkins Med Inst, Dept Pediat, Baltimore, MD 21205 USA
关键词
D O I
暂无
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
42
引用
收藏
页码:27 / 28
页数:2
相关论文
共 50 条
  • [1] Predictors of Outpatient and Inpatient Service Utilization Among Publicly-Insured Youth With Eating Disorders
    Mikhail, Megan E.
    Cordell, Kate Duggento
    Downey, Amanda E.
    Snowden, Lonnie R.
    Accurso, Erin C.
    INTERNATIONAL JOURNAL OF EATING DISORDERS, 2025, 58 (01) : 181 - 192
  • [2] Risk of Incident Type 2 Diabetes Following Anticonvulsant-Mood Stabilizer Treatment Initiation in Publicly Insured US Youth
    Burcu, Mehmet
    Zito, Julie M.
    Safer, Daniel J.
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2017, 26 : 27 - 27
  • [3] Psychotropic medication use among publicly insured US youth
    Valluri, Satish C.
    Kouzis, Anthony
    Zito, Julie M.
    Gardner, James F.
    Korelitz, James
    Bethel, James
    Lasky, Tamar
    Gerber, Russell A.
    Safer, Daniel J.
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2006, 15 : S14 - S14
  • [4] Health Care Utilization and Costs of Publicly-Insured Children with Diabetes in California
    Lee, Joyce M.
    Sundaram, Vandana
    Sanders, Lee
    Chamberlain, Lisa
    Wise, Paul
    JOURNAL OF PEDIATRICS, 2015, 167 (02): : 449 - +
  • [5] Impact of comorbid disruptive disorders on pharmacotherapy for attention-deficit/hyperactivity disorder in publicly-insured US youth
    Zito, Julie M.
    Valluri, Satish
    Hundley, Sarah D.
    Safer, Daniel J.
    Gardner, James F.
    Maneval, Mark
    Korelitz, James J.
    McNally, Diane L.
    Taylor-Zapata, Perdita
    Mattison, Donald R.
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2008, 17 : S198 - S199
  • [6] Feasibility of Continuous Glucose Monitor Use in Publicly Insured Youth with Type 2 Diabetes
    Shah, Sejal
    Arrizon-Ruiz, Nora
    Loyola, Alondra
    Sagan, Piper
    Conrad, Barry P.
    Leverenz, Jeannine
    Bishop, Franziska K.
    Maahs, David M.
    DIABETES, 2023, 72
  • [7] Interaction of Age and Psychiatric Diagnosis on Antipsychotic Use among Publicly-Insured Youth with ADHD or Disruptive Behavior Disorders
    Burcu, Mehmet
    Zito, Julie M.
    Safer, Daniel J.
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2013, 22 : 512 - 513
  • [8] Disparities in access to eating disorders treatment for publicly-insured youth and youth of color: a retrospective cohort study
    Moreno, Ruby
    Buckelew, Sara M.
    Accurso, Erin C.
    Raymond-Flesch, Marissa
    JOURNAL OF EATING DISORDERS, 2023, 11 (01)
  • [9] Disparities in access to eating disorders treatment for publicly-insured youth and youth of color: a retrospective cohort study
    Ruby Moreno
    Sara M. Buckelew
    Erin C. Accurso
    Marissa Raymond-Flesch
    Journal of Eating Disorders, 11
  • [10] Second Generation Antipsychotics and Risk of Type 2 Diabetes in Publicly Insured Children and Adolescents
    Gerhard, Tobias
    Bobo, William V.
    Olfson, Mark
    Correll, Christoph U.
    Huang, Cecilia
    Crystal, Stephen
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2014, 23 : 316 - 316